Serum neurofilament light protein predicts clinical outcome in traumatic brain injury

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Shahim, Pashtun ^a   Gren, Magnus ^a   Liman, Victor ^a   Andreasson, Ulf ^a   Norgren, Niklas ^b   Tegner, Yelverton ^c   Mattsson, Niklas ^d   Andreasen, Niels ^e   Öst, Martin ^a   Zetterberg, Henrik ^a,f   Nellgård, Bengt ^a   Blennow, Kaj ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UmanDiagnostics AB   (Sweden)

^c LULEÅ UNIVERSITY OF TECHNOLOGY   (Sweden)

^d LUND UNIVERSITY   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; NEUROFILAMENT PROTEIN; NEUROFILAMENT PROTEIN L; PROTEIN S100B; S100B PROTEIN, HUMAN;

ADULT; AREA UNDER THE CURVE; AXON; BLOOD; CASE CONTROL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOASSAY; MALE; METABOLISM; MIDDLE AGED; NERVE CELL; PATHOLOGY; PROGNOSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; AREA UNDER CURVE; AXONS; BIOMARKERS; BRAIN INJURIES, TRAUMATIC; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; NEUROFILAMENT PROTEINS; NEURONS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84994908954     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep36791     Document Type: Article

References (47)

1. Murray, C. J., & Lopez, A. D. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349, 1436-1442, doi: 10.1016/S0140-6736(96)07495-8 (1997
2. Collaborators, M. C. T., et al. Predicting outcome after traumatic brain injury: practical prognostic models based on large cohort of international patients. Bmj 336, 425-429, doi: 10.1136/bmj.39461.643438.25 (2008
3. Murray, G. D., et al. Multivariable prognostic analysis in traumatic brain injury: results from the IMPACT study. Journal of neurotrauma 24, 329-337, doi: 10.1089/neu.2006.0035 (2007
4. Steyerberg, E. W., et al. Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics. PLoS medicine 5, e165 discussion e165, doi: 10.1371/journal.pmed.0050165 (2008
5. Smith, D. H., Meaney, D. F., & Shull, W. H. Diffuse axonal injury in head trauma. The Journal of head trauma rehabilitation 18, 307-316 (2003
6. Zetterberg, H., Smith, D. H., & Blennow, K. Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood. Nature reviews. Neurology 9, 201-210, doi: 10.1038/nrneurol.2013.9 (2013
7. Lepinoux-Chambaud, C., & Eyer, J. Review on intermediate filaments of the nervous system and their pathological alterations. Histochemistry and cell biology 140, 13-22, doi: 10.1007/s00418-013-1101-1 (2013
8. Zetterberg, H., et al. Neurochemical aftermath of amateur boxing. Archives of neurology 63, 1277-1280, doi: 10.1001/archneur.63.9.1277 (2006
9. Routsi, C., et al. Increased levels of serum S100B protein in critically ill patients without brain injury. Shock 26, 20-24, doi: 10.1097/01.shk.0000209546.06801.d7 (2006
10. Stalnacke, B. M., Ohlsson, A., Tegner, Y., & Sojka, P. Serum concentrations of two biochemical markers of brain tissue damage S-100B and neurone specific enolase are increased in elite female soccer players after a competitive game. British journal of sports medicine 40, 313-316, doi: 10.1136/bjsm.2005.021584 (2006
11. Hasselblatt, M., et al. Serum S100beta increases in marathon runners reflect extracranial release rather than glial damage. Neurology 62, 1634-1636 (2004
12. Shahim, P., et al. Blood biomarkers for brain injury in concussed professional ice hockey players. JAMA neurology 71, 684-692, doi: 10.1001/jamaneurol.2014.367 (2014
13. Martinez-Morillo, E., et al. Neurofilament medium polypeptide (NFM) protein concentration is increased in CSF and serum samples from patients with brain injury. Clinical chemistry and laboratory medicine: CCLM/FESCC 53, 1575-1584, doi: 10.1515/cclm-2014-0908 (2015
14. Gatson, J. W., et al. Detection of neurofilament-H in serum as a diagnostic tool to predict injury severity in patients who have suffered mild traumatic brain injury. Journal of neurosurgery 121, 1232-1238, doi: 10.3171/2014.7.JNS132474 (2014
15. Heins, S., et al. The rod domain of NF-L determines neurofilament architecture, whereas the end domains specify filament assembly and network formation. The Journal of cell biology 123, 1517-1533 (1993
16. Lee, M. K., Xu, Z., Wong, P. C., & Cleveland, D. W. Neurofilaments are obligate heteropolymers in vivo. The Journal of cell biology 122, 1337-1350 (1993
17. Al Nimer, F., et al. Comparative Assessment of the Prognostic Value of Biomarkers in Traumatic Brain Injury Reveals an Independent Role for Serum Levels of Neurofilament Light. PloS one 10, e0132177, doi: 10.1371/journal.pone.0132177 (2015
18. Rissin, D. M., et al. Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nature biotechnology 28, 595-599, doi: 10.1038/nbt.1641 (2010
19. Neselius, S., et al. CSF-biomarkers in Olympic boxing: diagnosis and effects of repetitive head trauma. PloS one 7, e33606, doi: 10.1371/journal.pone.0033606 (2012
20. Kuhle, J., et al. Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa. Clinical chemistry and laboratory medicine: CCLM/FESCC, doi: 10.1515/cclm-2015-1195 (2016
21. Barry, D. M., Millecamps, S., Julien, J. P., & Garcia, M. L. New movements in neurofilament transport, turnover and disease. Experimental cell research 313, 2110-2120, doi: 10.1016/j.yexcr.2007.03.011 (2007
22. Narayan, R. K., et al. Clinical trials in head injury. Journal of neurotrauma 19, 503-557, doi: 10.1089/089771502753754037 (2002
23. Al Nimer, F., et al. Strain influences on inflammatory pathway activation, cell infiltration and complement cascade after traumatic brain injury in the rat. Brain, behavior, and immunity 27, 109-122, doi: 10.1016/j.bbi.2012.10.002 (2013
24. Zhou, W., et al. Meta-analysis of APOE4 allele and outcome after traumatic brain injury. Journal of neurotrauma 25, 279-290, doi: 10.1089/neu.2007.0489 (2008
25. Ercole, A., Thelin, E. P., Holst, A., Bellander, B. M., & Nelson, D. W. Kinetic modelling of serum S100b after traumatic brain injury. BMC neurology 16, 93, doi: 10.1186/s12883-016-0614-3 (2016
26. Thelin, E. P., Nelson, D. W., & Bellander, B. M. Secondary peaks of S100B in serum relate to subsequent radiological pathology in traumatic brain injury. Neurocritical care 20, 217-229, doi: 10.1007/s12028-013-9916-0 (2014
27. Berger, R. P., Bazaco, M. C., Wagner, A. K., Kochanek, P. M., & Fabio, A. Trajectory analysis of serum biomarker concentrations facilitates outcome prediction after pediatric traumatic and hypoxemic brain injury. Developmental neuroscience 32, 396-405, doi: 10.1159/000316803 (2010
28. Raabe, A., et al. S-100B protein as a serum marker of secondary neurological complications in neurocritical care patients. Neurological research 26, 440-445, doi: 10.1179/016164104225015958 (2004
29. Lingsma, H. F., Roozenbeek, B., Steyerberg, E. W., Murray, G. D., & Maas, A. I. Early prognosis in traumatic brain injury: from prophecies to predictions. Lancet neurology 9, 543-554, doi: 10.1016/S1474-4422(10)70065-X (2010
30. Metting, Z., Wilczak, N., Rodiger, L. A., Schaaf, J. M., & van der Naalt, J. GFAP and S100B in the acute phase of mild traumatic brain injury. Neurology 78, 1428-1433, doi: 10.1212/WNL.0b013e318253d5c7 (2012
31. Ryb, G. E., et al. S-100beta does not predict outcome after mild traumatic brain injury. Brain injury: [BI] 28, 1430-1435, doi: 10.3109/02699052.2014.919525 (2014
32. Korfias, S., et al. Serum S-100B protein monitoring in patients with severe traumatic brain injury. Intensive care medicine 33, 255-260, doi: 10.1007/s00134-006-0463-4 (2007
33. Vos, P. E., et al. GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study. Neurology 75, 1786-1793, doi: 10.1212/WNL.0b013e3181fd62d2 (2010
34. Magnoni, S., et al. Tau elevations in the brain extracellular space correlate with reduced amyloid-beta levels and predict adverse clinical outcomes after severe traumatic brain injury. Brain: a journal of neurology 135, 1268-1280, doi: 10.1093/brain/awr286 (2012
35. Skillback, T., et al. CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival. Neurology 83, 1945-1953, doi: 10.1212/WNL.0000000000001015 (2014
36. Tortorella, C., et al. Cerebrospinal fluid neurofilament tracks fMRI correlates of attention at the first attack of multiple sclerosis. Multiple sclerosis 21, 396-401, doi: 10.1177/1352458514546789 (2015
37. Lu, C. H., et al. Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis. Neurology, doi: 10.1212/WNL.0000000000001642 (2015
38. Zetterberg, H., et al. Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression. JAMA neurology 73, 60-67, doi: 10.1001/jamaneurol.2015.3037 (2016
39. Ljungqvist, J., Zetterberg, H., Mitsis, M., Blennow, K., & Skoglund, T. Serum neurofilament light protein as a marker for diffuse axonal injury -results from a case series study. Journal of neurotrauma In press (2016
40. Eikelenboom, M. J., et al. Multiple sclerosis: Neurofilament light chain antibodies are correlated to cerebral atrophy. Neurology 60, 219-223 (2003
41. Wilson, J. T., Pettigrew, L. E., & Teasdale, G. M. Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. Journal of neurotrauma 15, 573-585 (1998
42. Jennett, B., & Bond, M. Assessment of outcome after severe brain damage. Lancet 1, 480-484 (1975
43. Isoniemi, H., Tenovuo, O., Portin, R., Himanen, L., & Kairisto, V. Outcome of traumatic brain injury after three decades-relationship to ApoE genotype. Journal of neurotrauma 23, 1600-1608, doi: 10.1089/neu.2006.23.1600 (2006
44. Maas, A. I., Hukkelhoven, C. W., Marshall, L. F., & Steyerberg, E. W. Prediction of outcome in traumatic brain injury with computed tomographic characteristics: a comparison between the computed tomographic classification and combinations of computed tomographic predictors. Neurosurgery 57, 1173-1182 discussion 1173-1182 (2005
45. Blennow, K., Hardy, J., & Zetterberg, H. The neuropathology and neurobiology of traumatic brain injury. Neuron 76, 886-899, doi: 10.1016/j.neuron.2012.11.021 (2012
46. Norgren, N., Rosengren, L., & Stigbrand, T. Elevated neurofilament levels in neurological diseases. Brain research 987, 25-31 (2003
47. Breiman, L., Friedman, J., Olshen, R. A., & Stone, C. I. Classification and Regression Trees. (Boca Raton: FL CRC Press, 1984